Skip to main content
Selank Source

A scholarly research digest on Selank — the tuftsin-analog anxiolytic heptapeptide, its GABAergic, enkephalinase, BDNF and monoamine signals, and an honest map of where the evidence is single-region and thin.

Correspondence · editorial only

Contact Selank Source

Editorial questions, corrections, and source suggestions are welcome.

Read the researchSee the references

Editorial correspondence

Selank Source is a sourcebook for the Selank literature, and this contact page is for editorial correspondence only. We welcome corrections, pointers to peer-reviewed Selank studies we may have missed, and questions about how a particular finding on the site was sourced. We read every message in that spirit.

We cannot and do not offer medical advice, individual health guidance, or any recommendation about using Selank. There is no clinic here and no clinicians on staff.

What we cannot help with

We do not sell, supply, source, or ship Selank or any other product, and we cannot answer purchasing, pricing, or sourcing questions — there is nothing for sale here. We cannot recommend a dose, a protocol, or a supplier, and we will not. For any decision involving your health, please consult a qualified healthcare professional. Anxiety that is persistent or impairing is a treatable medical condition that deserves proper evaluation, not self-experimentation with an unapproved research compound.

Send a message

Use the form below to reach the editorial desk. Please include the page and the citation number you are writing about if your message concerns a specific finding, so we can respond precisely. We aim to acknowledge editorial and correction requests, and we prioritize sourcing corrections.